[1] Zhu HD, Tian P, Guan LJ, et al.Analysis and structural identification of relevant substances in Breviscapine for injection[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(6): 1350-1356. [2] Deng QL. Analysis of adverse reactions of breviscapine for injec-tion[J]. Journal of Contemporary Clinical Medicine(当代临床医刊), 2019, 32(2): 172, 175. [3] Wei WT, Chen S, Wang L, et al.Breviscapine induced the apoptosis of non-small cell lung cancer A549 cells[J]. Chinese Journal of Clinical Pharmacology and Therapeutics(中国临床药理学与治疗学), 2020, 25(6): 618-624. [4] Li YY, Guo RJ, Xie YM, et al.Expert consensus on Injection of Breviscapine in clinical practice[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(10): 2296-2299. [5] Zhao J, Zhang YL, Zhi YJ, et al.Efficacy and safety of breviscapine injection in the treatment of acute cerebral infarction:systematic review and meta-analysis of randomized controlled trials[J]. Journal of Traditional Chinese Medicine(中医杂志), 2019, 60(2): 123-130. [6] Zhi YJ, Zhao J, Zhao H, et al.Efficacy and safety of breviscapine injection in treatment of unstable angina pectoris: systematic review and Meta-analysis[J]. China Journal of Chinese Materia Medica, 2018, 43(19): 3940-3955. [7] Zhang YF, Ke XT, Li BC, et al.Meta-analysis on indirect comparison of Erigeron breviscapus injection and Breviscapus injection in treatment of acute ischemic stroke[J]. China Journal of Chinese Materia Medica, 2017, 42(6): 3940-3955. [8] Chengfeng JM, Xie YM, Wang LX, et al.Real world study on the influencing factors of breviscapine injection suspected allergic reaction[J]. Journal of Traditional Chinese Medicine(中医杂志), 2020, 61(24): 2174-2178. [9] Zhang S, Liu JY, Zhao L, et al.Analysis of 204 cases of adverse drug reactions caused by breviscapine injection[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2016, 36(18): 1585-1588. [10] LI YY, Tang H, Li L, et al.Effect of Dengzhan Xixin injection dosage on renal function using propensity score estimation[J].Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2016, 36(12): 1430-1434. [11] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China[S]. Beijing: China Medical Science Press(中华人民共和国药典), 2015: 1341. [12] Garovic VD, August P.Sex differences and renal protection: keeping in touch with your feminine side[J]. J Am Soc Nephrol, 2016, 27(10): 2921-2924. [13] Hodeify R, Megyesi J, Tarcsafalvi A, et al.Gender differences control the susceptibility to ER stress-induced acute kidney injury[J]. Am J Physiol Renal Physiol, 2013, 304(7): F875-F882. [14] Kang KP, Lee JE, Lee AS, et al.Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice[J]. Mol Med Rep, 2014, 9(6): 2061-2068 [15] Mitchell T, De Miguel C, Gohar EY.Sex differences in redox homeostasis in renal disease[J]. Redox Biol, 2020, 31: 101489. [16] Park KM, Kim JI, Ahn Y, et al.Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury[J]. J Biol Chem, 2004, 279(50): 52282-52292 [17] Schiffl H.Gender differences in the susceptibility of hospital-acquired acute kidney injury: more questions than answers[J]. Int Urol Nephrol, 2020, 52(10): 1911-1914. [18] Shi M, Zhou L, Fu P.The mechanism of estrogen in renal protection in renal diseases[J]. Chinese Journal of Integrated Traditional and Western Nephrology(中国中西医结合肾病杂志), 2018, 19(2): 170-172. [19] Wang SL.Clinical efficacy of breviscapine tablets combined with losartan in the treatment of chronic glomerulonephritis[J]. Chronic Pathematology Journal(慢性病学杂志), 2019, 20(4): 614-615, 618. [20] Xv LJ, Zhang X, Chen RC, et al.Progress in prevention and treatment of diabetic complications with breviscapine[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2020, 26(7): 218-224. [21] Magboul SM, Osman B, Elnour AA.The incidence, risk factors, and outcomes of acute kidney injury in the intensive care unit in Sudan[J]. Int J Clin Pharm, 2020, 42(6): 1447-1455. [22] Liu X.There is incompatibility between breviscapine for injection and furosemide injection[J]. The Journal of Medical Theory and Practice(医学理论与实践), 2011, 24(16): 1996. [23] Bagshaw SM, Gibney RTN, Kruger P, et al.The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study)[J]. J Crit Care, 2017, 42: 138-146. [24] Krzych ŁJ, Czempik PF.Impact of furosemide on mortality and the requirement for renal replacement therapy in acute kidney injury: a systematic review and meta-analysis of randomised trials[J]. Ann Intensive Care, 2019, 9(1): 85. [25] Valdespino-Trejo A, Orea-Tejeda A, Castillo-Martínez L, et al.Low albumin levels and high impedance ratio as risk factors for worsening kidney function during hospitalization of decompensated heart failure patients[J]. Experimental and Clinical Cardiology, 2013, 18(2): 113-117. [26] Rimmele T, Karajala V, Murugan R, et al.Use of loop diuretics in the critically ill[J]. Contrib Nephrol, 2010, 165: 219-225. [27] Feng Y, Chen HY, Yao GT, et al.Meta-analysis of clinical adverse reactions induced by breviscapine injection[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine(上海中医药大学学报), 2016, 30(4): 85-91. [28] Li L, Ge QL, Guo SM, et al.Logistic regression analysis on influential factors of adverse reactions caused by Breviscapine for Injection[J]. Journal of Pharmaceutical Research(药学研究), 2015, 34(8): 494-496. [29] Zhang GH, Lyu J, Wu XW, et al.Effect of injection of breviscapine on liver function in real world[J]. Liaoning Journal of Traditional Chinese Medicine(辽宁中医杂志), 2021, 48(5): 145-150. |